Fennec Pharmaceuticals Inc. (FENC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 220.04M |
| Enterprise Value | 183.32M |
| P/E Ratio | -31.03 |
| PEG Ratio | -2.22 |
| Price/Sales Ratio | 5.34 |
| Price/Book Ratio | 8.69 |
| Enterprise/Revenue | 4.55 |
| Enterprise/EBITDA | -34.8 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.16 |
| Operating Margin | -0.11 |
| Return On Assets | -0.12 |
| Return On Equity | -0.55 |
| Revenue | 44.64M |
| Revenue/Share | 1.49 |
| Gross Profit | 40.88M |
| EBITDA | -7.45M |
| Net Income | -9.74M |
| Diluted EPS | -0.36 |
| Total Cash | 40.18M |
| Total Cash/Share | 1.17 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.98 |
| Book Value Per Share | 1.1 |
| 52-Week Change | 18.09 |
| 52-Week High | 10.45 |
| 52-Week Low | 5.65 |
| Moving Average 50 Days | 8.07 |
| Moving Average 200 Days | 8.04 |
| Average Volume | 268,475 |
| Shares Outstanding | 28.58M |
| % Held by Institutions | 56.69 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
| Last Split Date | September 09, 2014 |